Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2025-12-25 @ 12:41 PM
NCT ID:
NCT01755195
Group ID:
EG000
Title:
Cabozantinib
Description:
60 mg tablets orally once a day in a 28-day cycle.
Cabozantinib: Cabozantinib inhibits multiple receptor tyrosine kinases (RTKs) implicated in tumor growth, metastasis, and angiogenesis, and targets primarily mesenchymal-epithelial transition factor (MET) and vascular endothelial growth factor receptor 2 (VEGFR2).
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
54
Other Number Affected:
53
Other Number At Risk:
54
Study:
NCT01755195
Results Section:
NCT01755195
Adverse Events Module:
NCT01755195